New-onset anxiety in adults aged 50+ doubles risk of developing Parkinson's disease

In a recent study published in The British Journal of General Practice, researchers investigated Parkinson's disease (PD) risk among individuals with new-onset anxiety and associated risk factors.

Study: Risk of Parkinson’s disease in people aged ≥50 years with new-onset anxiety: a retrospective cohort study in UK primary care. Image Credit: Inside Creative House/Shutterstock.com
Study: Risk of Parkinson’s disease in people aged ≥50 years with new-onset anxiety: a retrospective cohort study in UK primary care. Image Credit: Inside Creative House/Shutterstock.com

Background

Anxiety problems are common among older individuals, frequently beginning early in life and connected to cognitive impairment. PD has the second-highest prevalence rate among neurodegenerative disorders worldwide, causing symptoms of motor and non-motor type. Anxiety is more prevalent in PD patients, but the PD risk in individuals aged 50 years and above with incident anxiety is unclear.

Previous research indicating that anxiety or anxiolytic prescriptions increased the risk of developing Parkinson's disease failed to account for lifestyle characteristics, socioeconomic position, and prodromal aspects. The Health Professionals Follow-Up Study (HPFS) examined PD incidence over 12 years among male and predominantly White healthcare personnel.

About the study

In the present retrospective cohort study, researchers evaluated Parkinson's disease incidence among individuals aged 50 years and above presenting with and without anxiety. They also explored clinical signs and symptoms that may increase PD risk among anxious individuals.

The researchers examined primary care data from the United Kingdom from 2008 to 2018, focusing on individuals over the age of 50 who had experienced incident anxiety. They obtained IQVIA Medical Research Data (IMRD), comprising de-identified information of The Health Improvement Network (THIN), including routine electronic medical records collected using In Practice Systems (IPS) or Vision GP. The researchers also included general practice data meeting the acceptable mortality reporting (AMR) and acceptable computer usage (ACU) requirements.

Participants in THIN were 50 to 99 years old, enrolled in participating practices between January 1, 2008, and December 31, 2018, with records of one or more anxiety episodes in the general practitioner database following a year without previous anxiety episodes. During the first report of anxiety, the researchers paired each participant with four unexposed individuals, matching for gender and age. They used the incident and dynamic group approach or exposure density sampling, in which individuals could initially function as controls and may subsequently become exposed (if they acquire anxiety).

The researchers used Weibull survival regressions to predict the time to Parkinson's disease among individuals with anxiety and those without and determine PD risk in anxious individuals. They estimated the hazard ratios (HR), adjusting for sociodemographic variables and lifestyle behaviors [age, biological sex, body mass index (BMI), socioeconomic deprivation, smoking status, and alcohol use], and significant mental and physical health issues.

The researchers used survival estimations to plot the progression of patients with and without anxiety. They investigated the existence of PD risk and associated prodromal characteristics in the period between the diagnosis of anxiety and one year before PD diagnosis. They visually assessed proportional hazard assumptions for survival modeling. They accounted for missing covariate data by multiple imputations using chained equations.

Results

There were 70,925 women and 38,510 men diagnosed with their initial episode of anxiety, whereas the unexposed cohort comprised 553,586 women and 324,670 men. Sleep problems, constipation, exhaustion, and sadness were typical prodromal symptoms among anxious individuals. In total, 331 individuals with anxiety acquired Parkinson's disease during follow-up, with a median duration of five years between the initial anxiety episode and Parkinson's disease diagnosis. Parkinson's disease incidence rates among those with anxiety and without were 1.0 and 0.5 per 1,000 individual years, respectively.

After adjusting for age, gender, lifestyle characteristics, social deprivation, head trauma, severe mental disease, and dementia, the risk of Parkinson's disease doubled compared to the non-anxious group. In addition, non-anxious individuals lived longer without acquiring Parkinson's disease than anxious people did. Women (HR, 0.4) and individuals from the most impoverished socioeconomic backgrounds (HR, 0.6) had a lower PD risk.

Symptoms associated with Parkinson's disease development among anxious individuals were motor features such as tremors (HR, 21), rigidity (HR, 5.1), balance impairments (HR, 4.2), autonomic features such as low blood pressure (HR, 4.0), and constipation (HR, 2.6), sleep disturbances (HR, 2.2), cognitive impairment (HR, 1.8), fatigue (HR, 1.8), and depression (HR, 1.7).

Conclusion

The study findings showed that anxiety considerably elevates Parkinson's disease risk among individuals aged ≥50 years, with a two-fold increase in risk for those with anxiety as the initial presentation. Depression, sleep disruption, cognitive impairment, fatigue, hypotension, tremors, stiffness, constipation, and balance impairment increase Parkinson's disease risk.

Further research could determine the relationship between anxiety and other prodromal symptoms, which might lead to earlier diagnosis and better management of Parkinson's disease and an increased risk of PD in those over the age of 50.

Journal reference:
  • Juan Carlos Bazo-Alvarez, Danielle Nimmons, Kate Walters, Irene Petersen, Anette Schrag, Risk of Parkinson's disease in people aged ≥50 years with new-onset anxiety: a retrospective cohort study in UK primary care, British Journal of General Practice, 24 June 2024; BJGP.2023.0423. DOI: 10.3399/BJGP.2023.0423

Pooja Toshniwal Paharia

Written by

Pooja Toshniwal Paharia

Pooja Toshniwal Paharia is an oral and maxillofacial physician and radiologist based in Pune, India. Her academic background is in Oral Medicine and Radiology. She has extensive experience in research and evidence-based clinical-radiological diagnosis and management of oral lesions and conditions and associated maxillofacial disorders.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Toshniwal Paharia, Pooja Toshniwal Paharia. (2024, June 27). New-onset anxiety in adults aged 50+ doubles risk of developing Parkinson's disease. News-Medical. Retrieved on December 08, 2024 from https://www.news-medical.net/news/20240627/New-onset-anxiety-in-adults-aged-502b-doubles-risk-of-developing-Parkinsons-disease.aspx.

  • MLA

    Toshniwal Paharia, Pooja Toshniwal Paharia. "New-onset anxiety in adults aged 50+ doubles risk of developing Parkinson's disease". News-Medical. 08 December 2024. <https://www.news-medical.net/news/20240627/New-onset-anxiety-in-adults-aged-502b-doubles-risk-of-developing-Parkinsons-disease.aspx>.

  • Chicago

    Toshniwal Paharia, Pooja Toshniwal Paharia. "New-onset anxiety in adults aged 50+ doubles risk of developing Parkinson's disease". News-Medical. https://www.news-medical.net/news/20240627/New-onset-anxiety-in-adults-aged-502b-doubles-risk-of-developing-Parkinsons-disease.aspx. (accessed December 08, 2024).

  • Harvard

    Toshniwal Paharia, Pooja Toshniwal Paharia. 2024. New-onset anxiety in adults aged 50+ doubles risk of developing Parkinson's disease. News-Medical, viewed 08 December 2024, https://www.news-medical.net/news/20240627/New-onset-anxiety-in-adults-aged-502b-doubles-risk-of-developing-Parkinsons-disease.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New Marie Skłodowska-Curie Doctoral Network advances AI solutions for Parkinson’s disease